Rating History for Cognition Therapeutics (CGTX) by Cantor Fitzgerald

More Stocks Rated by Cantor Fitzgerald | Latest Ratings for CGTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/30/2024 Charles Duncan Downgrade Neutral
(Overweight)		 N/A
(N/A)		 2.37
(1.03)		 -56.54% Details